{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:22:28Z","timestamp":1790403748254,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":1846,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ajt.14337","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T20:10:05Z","timestamp":1493323805000},"page":"2782-2789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cutaneous Toxicities From Transplantation-Related Medications"],"prefix":"10.1016","volume":"17","author":[{"given":"M.","family":"Ilyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.R.","family":"Colegio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14337_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.TP.0000165093.13046.B3","article-title":"Polyclonal antibody-induced serum sickness in renal transplant recipients: Treatment with therapeutic plasma exchange","volume":"80","author":"Tanriover","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1081-1206(10)60699-0","article-title":"Serum sickness-like reactions after placement of sirolimus-eluting stents","volume":"98","author":"Rana","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/ajt.14337_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: Frequency, risk factors and patient\u2019s opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14337_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-4362.2001.01234.x","article-title":"A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy","volume":"40","author":"Kaidbey","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/ajt.14337_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-84-3-304","article-title":"Glucocorticosteroid therapy: Mechanisms of action and clinical considerations","volume":"84","author":"Fauci","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.14337_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1524-4725.2009.01094.x","article-title":"Striae distensae (stretch marks) and different modalities of therapy: An update","volume":"35","author":"Elsaie","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14337_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/ajt.14337_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000249288","article-title":"Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients","volume":"172","author":"Bencini","year":"1986","journal-title":"Dermatology"},{"key":"10.1111\/ajt.14337_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaad.2005.09.041","article-title":"Sebaceous hyperplasia and skin cancer in patients undergoing renal transplant","volume":"55","author":"Salim","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-0960.2011.00776.x","article-title":"Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients","volume":"52","author":"McDonald","year":"2011","journal-title":"Australas J Dermatol"},{"key":"10.1111\/ajt.14337_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/abd1806-4841.20153192","article-title":"Sebaceous hyperplasia: Systemic treatment with isotretinoin","volume":"90","author":"Tagliolatto","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1111\/ajt.14337_bib13","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/jid.2015.121","article-title":"Re-evaluating cyclosporine as a hair growth-promoting agent in human scalp hair follicles","volume":"135","author":"Hawkshaw","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14337_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-051x.2000.027002144.x","article-title":"Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus","volume":"27","author":"James","year":"2000","journal-title":"J Clin Periodontol"},{"key":"10.1111\/ajt.14337_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0030-4220(87)90007-7","article-title":"Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva","volume":"64","author":"McGaw","year":"1987","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1111\/ajt.14337_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.archoralbio.2014.12.007","article-title":"Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth?","volume":"60","author":"T\u00fcrko\u011flu","year":"2015","journal-title":"Arch Oral Biol"},{"key":"10.1111\/ajt.14337_bib17","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.transproceed.2004.09.059","article-title":"Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients","volume":"36","author":"Tokg\u00f6z","year":"2004","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.14337_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/08860220701263580","article-title":"Comparison of azithromycin and oral hygiene program in the treatment of cyclosporine-induced gingival hyperplasia","volume":"29","author":"Ramalho","year":"2007","journal-title":"Ren Fail"},{"key":"10.1111\/ajt.14337_bib19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0190-9622(08)80085-0","article-title":"Isotretinoin treatment of severe cystic acne in a heart transplant patient receiving cyclosporine: Consideration of drug interactions","volume":"24","author":"Abel","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2230.2007.02386.x","article-title":"Hypertrophic pseudofolliculitis in white renal transplant recipients","volume":"32","author":"Lally","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ajt.14337_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.tp.0000181195.67084.94","article-title":"Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients","volume":"80","author":"Tricot","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archderm.1993.01680240096017","article-title":"Telogen effluvium. New concepts and review","volume":"129","author":"Headington","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14337_bib23","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1517\/14656566.2015.1084501","article-title":"Treatments options for alopecia","volume":"16","author":"Iorizzo","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/ajt.14337_bib24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/00054725-200409000-00034","article-title":"Hypersensitivity reaction to azathioprine in a patient with ulcerative colitis. Infrequent manifestations","volume":"10","author":"Mayo","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/ajt.14337_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaad.2010.04.041","article-title":"The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome","volume":"65","author":"Bidinger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: The past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2230.1995.tb01343.x","article-title":"Azathioprine hypersensitivity-like reactions: A case report and a review of the literature","volume":"20","author":"Knowles","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ajt.14337_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/pgmj.72.849.437","article-title":"Leucocytoclastic vasculitis in a patient with azathioprine hypersensitivity","volume":"72","author":"Beckett","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1111\/ajt.14337_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-109-1-83_2","article-title":"Azathioprine and hypersensitivity vasculitis","volume":"109","author":"Bergman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.14337_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.49.1.25","article-title":"Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis","volume":"49","author":"Jeurissen","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/ajt.14337_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/ard.60.7.719a","article-title":"Azathioprine hypersensitivity","volume":"60","author":"Sofat","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/ajt.14337_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.dld.2003.10.020","article-title":"Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: A case of Sweet\u2019s syndrome. Case report and review of literature","volume":"36","author":"Paoluzi","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1111\/ajt.14337_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1574886310666150729125620","article-title":"A rare case of azathioprine-induced Sweet\u2019s syndrome in a patient with Crohn\u2019s disease","volume":"10","author":"Ben Salem","year":"2015","journal-title":"Curr Drug Saf"},{"key":"10.1111\/ajt.14337_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1440-0960.2008.00503.x","article-title":"Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis","volume":"50","author":"Yiasemides","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1111\/ajt.14337_bib35","first-page":"161","article-title":"Adverse effects of azathioprine","volume":"3","author":"Lawson","year":"1984","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"key":"10.1111\/ajt.14337_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cncr.24696","article-title":"Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients","volume":"116","author":"Sonis","year":"2010","journal-title":"Cancer"},{"key":"10.1111\/ajt.14337_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1529-8019.2010.01324.x","article-title":"Aphthous ulcers","volume":"23","author":"Messadi","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1111\/ajt.14337_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib39","first-page":"33","article-title":"Mycophenolate mofetil: A promising immunosuppressive agent","volume":"52","author":"Kulkarni","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"10.1111\/ajt.14337_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","article-title":"Frequently relapsing nephrotic syndrome: Treatment with mycophenolate mofetil","volume":"19","author":"Gellermann","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.14337_bib41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0151-9638(07)92831-8","article-title":"Mouth ulcers induced by enteric-coated mycophenolate sodium (Myfortic)","volume":"134","author":"Miquel","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/ajt.14337_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2146\/ajhp100276","article-title":"Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient","volume":"68","author":"Weng","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/ajt.14337_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.transproceed.2006.12.028","article-title":"Oral ulcers produced by mycophenolate mofetil in two liver transplant patients","volume":"39","author":"Naranjo","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14337_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00007890-200109150-00043","article-title":"Oral ulcerations in a renal transplant recipient: A mycophenolate mofetil-induced complication?","volume":"72","author":"Garrigue","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib45","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/01.TP.0000123078.89315.93","article-title":"Mycophenolate mofetil and oral ulcerations","volume":"77","author":"Apostolou","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2005.11.1072","article-title":"Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspects","volume":"55","author":"Mahe","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mahe","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib48","first-page":"531","article-title":"Sirolimus-induced onychopathy in renal transplant recipients","volume":"133","author":"Mahe","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/ajt.14337_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/ajt.14337_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2010.01232.x","article-title":"mTOR inhibitor-associated dermatologic and mucosal problems","volume":"24","author":"Campistol","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.14337_bib52","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1600-6143.2006.01678.x","article-title":"Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus","volume":"7","author":"Chuang","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14337_bib53","first-page":"28","article-title":"Local presence of cytomegalovirus and Candida species vs oral lesions in liver and kidney transplant recipients","volume":"13","author":"Olczak-Kowalczyk","year":"2008","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.14337_bib54","unstructured":"Dioguardi M, Troiano G, Russo LL, et al. Occult co-infection in the oral cavity with cytomegalovirus during immuno-suppression. 2015."},{"key":"10.1111\/ajt.14337_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ajt.12511","article-title":"Palmoplantar peeling secondary to sirolimus therapy","volume":"14","author":"Liu","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14337_bib56","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14337_bib57","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib58","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000072016.13090.4E","article-title":"Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study","volume":"76","author":"Troppmann","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamadermatol.2016.3546","article-title":"Sirolimus-associated rapid progression of leg ulcers in a renal transplant recipient","volume":"153","author":"Totonchy","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14337_bib60","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/01.TP.0000093502.26208.42","article-title":"The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients","volume":"76","author":"Flechner","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/lrb.2007.5203","article-title":"Literature watch. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis","volume":"5","author":"Blei","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"10.1111\/ajt.14337_bib62","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1349-7006.2007.00439.x","article-title":"Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis","volume":"98","author":"Kobayashi","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1111\/ajt.14337_bib63","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.TP.0000128628.31556.B1","article-title":"A retrospective review of liver transplant patients treated with sirolimus from a single center: An analysis of sirolimus-related complications","volume":"78","author":"Montalbano","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002112","article-title":"Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis","volume":"71","author":"Huber","year":"2007","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.14337_bib65","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00007890-200209270-00012","article-title":"Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients","volume":"74","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1531003507313218","article-title":"Diagnosis and management of venous ulcers","volume":"20","author":"Carr","year":"2008","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"10.1111\/ajt.14337_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cnur.2015.10.008","article-title":"Immunosuppressive therapy in transplantation","volume":"51","author":"Allison","year":"2016","journal-title":"Nurs Clin North Am"},{"key":"10.1111\/ajt.14337_bib68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1399-3046.2004.00209.x","article-title":"Current immunosuppressive agents in pediatric renal transplantation: Efficacy, side-effects and utilization","volume":"8","author":"Smith","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.14337_bib69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14337_bib71","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1592\/phco.31.4.394","article-title":"Belatacept: A novel biologic for maintenance immunosuppression after renal transplantation","volume":"31","author":"Martin","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1111\/ajt.14337_bib72","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/TP.0b013e3182007b95","article-title":"An integrated safety profile analysis of belatacept in kidney transplant recipients","volume":"90","author":"Grinyo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14337_bib73","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.medmal.2011.09.016","article-title":"Phototoxicity and photocarcinogenesis associated with voriconazole","volume":"41","author":"Epaulard","year":"2011","journal-title":"Med Mal Infect"},{"key":"10.1111\/ajt.14337_bib74","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2125.2009.03534.x","article-title":"Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype","volume":"68","author":"Scholz","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ajt.14337_bib75","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/INF.0b013e3181d60a82","article-title":"Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole","volume":"29","author":"Frick","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/ajt.14337_bib76","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1086\/511685","article-title":"Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy","volume":"44","author":"McCarthy","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.14337_bib77","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1469-0691.2009.03124.x","article-title":"Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients","volume":"16","author":"Epaulard","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/ajt.14337_bib78","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.14337_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaad.2010.11.063","article-title":"Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients","volume":"65","author":"Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14337_bib80","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","author":"Feist","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.14337_bib81","doi-asserted-by":"crossref","first-page":"351084","DOI":"10.1155\/2010\/351084","article-title":"Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: A case report","volume":"2010","author":"Morice","year":"2010","journal-title":"Case Rep Med"},{"key":"10.1111\/ajt.14337_bib82","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archdermatol.2009.362","article-title":"Melanoma associated with long-term voriconazole therapy: A new manifestation of chronic photosensitivity","volume":"146","author":"Miller","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14337_bib83","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1524-4725.2010.01596.x","article-title":"Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole","volume":"36","author":"Ibrahim","year":"2010","journal-title":"Dermatol Surg"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352225196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352225196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14337\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:19:22Z","timestamp":1761628762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352225196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S160061352225196X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14337","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Toxicities From Transplantation-Related Medications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}